Back to Search
Start Over
PET2-driven de-escalation therapy in 64 high-risk Hodgk Lymphoma patients treated with escalated BEACOPP.
- Source :
- British Journal of Haematology; Jul2015, Vol. 170 Issue 2, p278-281, 4p
- Publication Year :
- 2015
-
Abstract
- The article discusses the use of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy in the treatment of Hodgkin lymphoma (HL) patients. Topics discussed include investigation of positron emission tomography (PET) driven dose-reduction strategy in patients, oral administration of etoposide, and adjustment of chemotherapy intensity.
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 170
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 108761823
- Full Text :
- https://doi.org/10.1111/bjh.13287